PTCT
Common StockPTC THERAPEUTICS, INC.
Reported Shares
875.3K
Position Mix
No options reported
Reported Value
$56.7M
Portfolio Weight
8.44%
Reported 13F portfolio for Q3 2026.
Reported 13F Portfolio Value
$672.2M
Data Refreshed
Nov 17, 2026
Portfolio Structure
Company profiles & logos by Twelve Data
PTCT
Common StockPTC THERAPEUTICS, INC.
Reported Shares
875.3K
Position Mix
No options reported
Reported Value
$56.7M
Portfolio Weight
8.44%
IOVA
Common StockIOVANCE BIOTHERAPEUTICS, INC.
Reported Shares
3.5M
Position Mix
No options reported
Reported Value
$51.4M
Portfolio Weight
7.65%
INSM
Common StockINSMED Inc
Reported Shares
443.6K
Position Mix
No options reported
Reported Value
$50.6M
Portfolio Weight
7.53%
ACAD
Common StockACADIA PHARMACEUTICALS INC
Reported Shares
2.5M
Position Mix
No options reported
Reported Value
$50.1M
Portfolio Weight
7.45%
BMRN
Common StockBIOMARIN PHARMACEUTICAL INC
Reported Shares
642.5K
Position Mix
No options reported
Reported Value
$38.5M
Portfolio Weight
5.73%
MIRM
Common StockMirum Pharmaceuticals, Inc.
Reported Shares
387.3K
Position Mix
No options reported
Reported Value
$33.1M
Portfolio Weight
4.93%
UTHR
Common StockUNITED THERAPEUTICS Corp
Reported Shares
58.9K
Position Mix
No options reported
Reported Value
$31.9M
Portfolio Weight
4.75%
DYN
Common StockDyne Therapeutics, Inc.
Reported Shares
1.9M
Position Mix
No options reported
Reported Value
$30.3M
Portfolio Weight
4.51%
BIIB
Common StockBIOGEN INC.
Reported Shares
132.9K
Position Mix
No options reported
Reported Value
$30.0M
Portfolio Weight
4.47%
ANAB
Common StockANAPTYSBIO, INC
Reported Shares
595.3K
Position Mix
No options reported
Reported Value
$29.9M
Portfolio Weight
4.45%
CDNA
Common StockCareDx, Inc.
Reported Shares
424.6K
Position Mix
No options reported
Reported Value
$27.6M
Portfolio Weight
4.11%
TRAX
Common StockFirst Tracks Biotherapeutics, Inc.
Reported Shares
741.1K
Position Mix
No options reported
Reported Value
$26.3M
Portfolio Weight
3.91%
IRON
Common StockDisc Medicine, Inc.
Reported Shares
396.5K
Position Mix
No options reported
Reported Value
$26.0M
Portfolio Weight
3.86%
NVCR
Common StockNovoCure Ltd
Reported Shares
1.2M
Position Mix
No options reported
Reported Value
$19.3M
Portfolio Weight
2.87%
BCAX
Common StockBicara Therapeutics Inc.
Reported Shares
689.3K
Position Mix
No options reported
Reported Value
$12.8M
Portfolio Weight
1.91%
ANNX
Common StockAnnexon, Inc.
Reported Shares
2.8M
Position Mix
No options reported
Reported Value
$11.9M
Portfolio Weight
1.77%
SNDX
Common StockSyndax Pharmaceuticals Inc
Reported Shares
596.4K
Position Mix
No options reported
Reported Value
$11.2M
Portfolio Weight
1.67%
CLDX
Common StockCelldex Therapeutics, Inc.
Reported Shares
343.1K
Position Mix
No options reported
Reported Value
$11.1M
Portfolio Weight
1.65%
RARE
Common StockUltragenyx Pharmaceutical Inc.
Reported Shares
710K
Position Mix
No options reported
Reported Value
$10.7M
Portfolio Weight
1.59%
PRTA
Common StockPROTHENA CORP PUBLIC LTD CO
Reported Shares
1.1M
Position Mix
No options reported
Reported Value
$9.5M
Portfolio Weight
1.41%